Home > Products > CD89 & HIV-1 gp41
> Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG)
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) (CAT#: SCIGG-133)
Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD89 and anti-HIV-1 gp41 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget macrophages to tumor cells. It is designed for the research of HIV-1 infection, AIDS therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scIgG) (SCIGG-133). Click the button below to contact us or submit your feedback about this product.